How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

And that's just for starters. Here's a quick primer on the vocabulary of today's arcane yet everyday technology.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

To show how training can lead to rogue behaviors, we built a simple A.I. model: a two-dimensional maze, much like the one in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Michael Boyle is an experienced ...

Armando Roggio is the longtime senior contributor to Practical Ecommerce. He's a global ecommerce authority and a practicing merchant, developer, and journalist. Since 2008 he's written over 1,300 ...

Which humanoid robots are closest to deployment in 2027? Compare Tesla, Figure AI, Agility Robotics, and other leaders in industrial automation. If you can only read one tech story a day, this is it.